March 25, 2009
GREENWICH, CT and ANN ARBOR, MI – Biotronic NeuroNetwork (“Biotronic”), a Great Point Partners I, L.P. (“GPP”) portfolio company and the nation’s leading intraoperative neurophysiological monitoring (“IONM”) company, is pleased to announce that it has been awarded the Gold Seal of ApprovalTM by the Joint Commission on Accreditation of Healthcare Organizations (“JCAHO”). Biotronic believes it is the first intraoperative neurophysiological monitoring provider to receive JCAHO accreditation.
As an independent, not-for-profit organization with a 50 year history, JCAHO is the nation’s largest and oldest health care evaluation and certifying agency for nearly 15,000 health care organizations and programs in the United States including hospitals, hospice services, nursing homes, laboratories, rehabilitation centers, and behavioral health care organizations. The JCAHO certification signifies that Biotronic meets rigorous national standards and performance measurements for health care quality and safety in improving patient outcomes during surgery.
Gene K. Balzer, PhD, Chief Executive Officer of Biotronic NeuroNetwork stated, “This is an important achievement for Biotronic, which represents our continual commitment to offering the highest level of quality and service to hospitals, surgeons and patients throughout the country.” Adam B. Dolder, Chairman of Biotronic and Managing Director at Great Point Partners adds, “This achievement further demonstrates that Biotronic is the premier provider of intraoperative neuromonitoring services. Dr. Balzer and the entire organization, have taken the lead in ensuring the highest quality and clinical standards in the IONM industry.”
Founded in 1978, Biotronic NeuroNetwork, is headquartered in Ann Arbor, MI and currently employs over 200 administrative, support and clinical staff, including over 150 technicians throughout 17 states. Biotronic is the largest independent provider of intraoperative neurophysiological monitoring in the world, serving over 400 hospitals and 1,200 surgeons annually. www.biotronic.com
About Great Point Partners, LLC
GPP, based in Greenwich, CT, is a leading health care investment firm with approximately $500 million of equity capital under management. The firm manages capital in public and private equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 health care companies. Both the private and public funds invest across all sectors of the health care industry including biotechnology and life sciences, consumer health, generic drugs, health care services, information technology, insurance, medical devices, specialty pharmaceuticals, and workers compensation. The firm pursues a proactive and proprietary approach to sourcing investments. Reach Great Point Partners at 203-971-3300. www.gppfunds.com
This document is intended solely to provide information regarding Great Point Partners’ potential financing capabilities for prospective portfolio companies.